John Prosper Mack - Aug 7, 2024 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Director
Signature
/s/ Andrew Taylor, Attorney-in-Fact
Stock symbol
OBIO
Transactions as of
Aug 7, 2024
Transactions value $
$0
Form type
4
Date filed
8/8/2024, 05:54 PM
Previous filing
Jul 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Award $0 +12.9K $0.00 12.9K Aug 7, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OBIO Stock Option (Right to Buy) Award $0 +40.7K $0.00 40.7K Aug 7, 2024 Common Stock 40.7K $5.83 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on August 7, 2024. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (1) 6,003 RSUs vest on June 20, 2025 and (2) the remaining 6,861 RSUs vest in three equal, annual installments beginning on August 7, 2025, subject to the Reporting Person's continuous service through such dates.
F2 The stock options shall vest as follows: (1) 19,218 stock options shall vest on June 20, 2025 and (2) the remaining 21,519 stock options shall vest in three equal, annual installments beginning on August 7, 2025, subject to the Reporting Person's continuous service through such date.